Home › Funds › Vestal Point Capital, LP › DMRA

Vestal Point Capital, LP position in DMRA

DAMORA THERAPEUTICS INC COM SHS · Health Care

Vestal Point Capital, LP reported holding 575,000 shares of DMRA (DAMORA THERAPEUTICS INC COM SHS) in its Q2 2026 13F filing — a position valued at US$15.0M, representing 0.35% of its reported portfolio and ranking #47 among its reported holdings. Vestal Point Capital, LP has disclosed DMRA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)575.00K sh
Reported value held$14.96M
Portfolio Weight0.35%
First reportedQ1 2026
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's DMRA position evolved

Vestal Point Capital, LP first disclosed a stake in DMRA in Q1 2026 at 600,000 shares (US$15.5M). Across 2 filings, Vestal Point Capital, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 575,000 shares valued at US$15.0M — a reduction of -25,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2026 600.00K $15.54M New
Q2 2026 575.00K $14.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DMRA and 13F data

DMRA (DAMORA THERAPEUTICS INC COM SHS) is a Health Care company. 105 other funds we track also report a position in DMRA — the largest reported positions include Fairmount Funds Management LLC (US$226.6M), Avoro Capital Advisors LLC (US$98.4M), Venrock Adviser, LLC (US$93.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DMRA

All DMRA fund holders →

FAQ

How long has Vestal Point Capital, LP held DMRA?

Vestal Point Capital, LP has disclosed DMRA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Vestal Point Capital, LP's current position in DMRA?

As of Q2 2026, Vestal Point Capital, LP holds 575.00K shares of DMRA (DAMORA THERAPEUTICS INC COM SHS), valued at $14.96M, representing 0.35% of its reported portfolio and ranking #47.

Has Vestal Point Capital, LP been buying or selling DMRA?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP reduced its position in DMRA.

Which other funds hold DMRA?

Other major institutional holders of DMRA include Fairmount Funds Management LLC, Avoro Capital Advisors LLC, Venrock Adviser, LLC, among 105 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.